Paul Weiss Rifkind Wharton & Garrison

Paul Weiss Rifkind Wharton & Garrison delivers a capable team of attorneys well-versed in patent litigation for life sciences companies, notably in biosimilars disputes and post-grant proceedings. "They produce really extraordinary work," a competitor says about the litigation team. Paul Weiss has one of the pioneering practices in the burgeoning area of litigations under the Biologics Price Competition and Innovation Act, a continuing area of focus for the firm. The firm received a top-tier ranking this year for patent litigation due to its significant activity in cutting edge IP disputes.

Nicholas Groombridge is a trial lawyer at the forefront of the biosimilars litigation space. One peer says Groombridge is "doing a bang-up job in biologics," while another offers, "He's a good lawyer, not only on his feet, but also a good writer as well." He also has deep experience in patent disputes related to pharmaceuticals and medical devices. Groombridge was recognized as the New York General Patent Litigator of the Year at the 2018 LMG Life Sciences Awards. Steven Baughman is the firm's expert in Patent Office disputes, an area of increasing strategic importance in life sciences IP. He was shortlisted for the Post-Grant Proceedings Attorney of the Year Award by LMG Life Sciences in 2018 for his strength in the area.

Eric Stone makes his debut as a star this year for his significant work in patent litigations related to large and small molecule products. A competitor describes Stone as "effective" and an "aggressive lawyer."